Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy.
Front Immunol. 2019 Dec 4;10:2784. doi: 10.3389/fimmu.2019.02784. eCollection 2019.
Front Immunol. 2019.
PMID: 31839796
Free PMC article.
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy.
Bari R, Granzin M, Tsang KS, Roy A, Krueger W, Orentas R, Schneider D, Pfeifer R, Moeker N, Verhoeyen E, Dropulic B, Leung W.
Bari R, et al. Among authors: moeker n.
Front Immunol. 2019 Aug 22;10:2001. doi: 10.3389/fimmu.2019.02001. eCollection 2019.
Front Immunol. 2019.
PMID: 31507603
Free PMC article.
Item in Clipboard
Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings.
Moeker N, Peters S, Rauchenberger R, Ghinea N, Kunz C.
Moeker N, et al.
Antibodies (Basel). 2017 Oct 18;6(4):15. doi: 10.3390/antib6040015.
Antibodies (Basel). 2017.
PMID: 31548530
Free PMC article.
Item in Clipboard
Cite
Cite